TP53 and cancer: To rule out the possibility of tumor heterogeneity contributing to TP53-ARID1A co-dependencies, Cancer Dependency Map (DepMap [53]) data suggested that TP53 mutant cancer cell lines were not more genetically dependent on ARID1A than TP53 wild-type lines (Fig 7A).